Stocksigma LogoStocksigma Logo

Sagility Reports Strong Q2 FY27 Results and Chirok Health Acquisition

Sagility Limited delivered solid Q2 FY27 consolidated revenue of ₹20,321 million, up 22.5% YoY (12.2% CC), driven by 24.4% growth in its Payer vertical

Sagility Reports Strong Q2 FY27 Results and Chirok Health Acquisition

Sagility Ltd · Financial Result · 23 Oct 2026, 12:05 am

Sagility Reports Strong Q2 FY27 Results and Chirok Health Acquisition Sagility Limited delivered solid Q2 FY27 consolidated revenue of ₹20,321 million, up 22.5% YoY (12.2% CC), driven by 24.4% growth in its Payer vertical. Adjusted EBITDA increased 23.0% YoY to ₹5,353 million with margins expanding to 26.3%, while reported PAT grew 13.3% YoY to ₹2,842.12 million. The company declared an interim dividend of ₹0.15 per share. In a key strategic move, Sagility signed a definitive agreement to acquire US-based Chirok Health LLC for up to US$32.35 million, bolstering its provider RCM and clinical documentation capabilities.

Original exchange filing (PDF)

More announcements from Sagility Ltd

All Sagility Ltd announcements